Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hit Hard and Early: Methylprednisolone in Early SSc
NCT03059979Phase 1Unknown
- Sponsor
- Radboud University Medical Center
- Start
- Jan 2017
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in systemic sclerosis (SSc) comparing Methylprednisolone with Placebo (2 arms). Primary endpoint: Change in nailfold capillary density at 12 weeks. Status: unknown.
02
Drugs
methylprednisolone injection
03
Conditions
systemic sclerosis (SSc)
Beyond the preview
Go deeper on NCT03059979.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059979.